MSH2 and Lynch syndrome: Mutations in essential genes for DNA repair, such as MutL Homolog 1 (MLH1) and MutS Homolog 2 (MSH2), which are also predominant in Lynch syndrome patients, also increase the risk of ovarian cancer (36).